5 Best Artificial Intelligence Stocks Under $20 According To Analysts

In this article, we discuss 5 best artificial intelligence stocks under $20 according to analysts. If you want to see more stocks in this selection, check out 10 Best Artificial Intelligence Stocks Under $20 According To Analysts. 

5. Lantronix, Inc. (NASDAQ:LTRX)

Average Estimated Price Target: $9.90

Number of Hedge Fund Holders: 10

Average Upside Potential: 116.45% 

Lantronix, Inc. (NASDAQ:LTRX) provides a variety of solutions for video surveillance, traffic management, infotainment systems, robotics, edge computing, and remote environment management applications. Its products include telematics devices that support communication across interfaces and industrial protocols for vehicle, fleet, and asset tracking and management, as well as network switches, media converters, power over Ethernet, NICS and optical SFPs, system-on-modules, single-board computers, and development kits. Additionally, Lantronix, Inc. (NASDAQ:LTRX) offers services related to mechanical, hardware, and software engineering for the development of camera, audio, and artificial intelligence/machine learning solutions.

On February 10, T. Michael Walkley, an analyst at Canaccord, maintained a Buy rating on Lantronix, Inc. (NASDAQ:LTRX) but reduced the firm’s price target on the shares from $11 to $10. The analyst noted that the company has reaffirmed its $40 million contract with Gridspertise, which is higher than their initial $30 million projection. As the larger deal is now postponed for two quarters into F2024, the analyst predicts strong revenue growth in F2024 with earnings leverage.

According to Insider Monkey’s fourth quarter database, 10 hedge funds were bullish on Lantronix, Inc. (NASDAQ:LTRX), with combined stakes worth $10.5 million. George McCabe’s Portolan Capital Management held the largest stake in the company.

 

4. Remark Holdings, Inc. (NASDAQ:MARK)

Average Estimated Price Target: $3.75

Number of Hedge Fund Holders: N/A

Average Upside Potential: 131.09%

Remark Holdings, Inc. (NASDAQ:MARK) concentrates on creating and implementing artificial intelligence solutions for software developers and businesses. The company operates a data and AI software platform named Remark AI in the US and KanKan AI in the Asia Pacific region. This platform provides AI-driven computer vision products, computing devices, and software-as-a-service solutions to different industries, including retail, urban life cycle, workplace and food safety, railway safety, and biosafety. On December 21, Remark Holdings, Inc. (NASDAQ:MARK) announced a 1-for-10 reverse stock split.

On January 17, Remark Holdings, Inc. (NASDAQ:MARK) disclosed a new collaboration with AAEON, a top AI-Edge computing provider. This partnership highlights the significance of offering ready-to-market solutions for developing smart cities that require visual solutions to enhance public safety, situational awareness, and behavior analysis. By integrating Remark Holdings, Inc. (NASDAQ:MARK)’s AI-powered video analytics with AAEON’s computing platforms, a straightforward solution for system integrators and end-users is created. The two companies can jointly develop and deploy an entire vision system that can quickly detect, identify, track, and analyze objects, individuals, vehicles, and behaviors at scale and velocity, with actionable insights and minimal false alerts.

3. Amesite Inc. (NASDAQ:AMST)

Average Estimated Price Target: $40.80

Number of Hedge Fund Holders: 2

Average Upside Potential: 1,075.79%

Amesite Inc. (NASDAQ:AMST) operates a platform and course designer that uses artificial intelligence to provide online products in the US. Their technology uses machine learning to create a personalized experience for learners. Their services are utilized by businesses, non-profit organizations, K-12 schools, universities, and colleges. Founded in 2017, Amesite Inc. (NASDAQ:AMST) is based in Detroit, Michigan. 

On April 3, the stock price of Amesite Inc. (NASDAQ:AMST) increased by 18% following the company’s announcement about the development of an AI platform. The platform is powered by GPT-4, Version 6.0, which is the same technology used in ChatGPT Plus and Microsoft’s new Bing.

According to Insider Monkey’s fourth quarter database, Israel Englander’s Millennium Management held 82,154 shares and Jim Simons’ Renaissance Technologies held 66,200 in Amesite Inc. (NASDAQ:AMST). 

2. Predictive Oncology Inc. (NASDAQ:POAI)

Average Estimated Price Target: $5.00

Number of Hedge Fund Holders: 2

Average Upside Potential: 1,819.39% 

Predictive Oncology Inc. (NASDAQ:POAI) is an American company that employs artificial intelligence to develop effective cancer treatments. The company operates in four segments – Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides AI-based predictive models to improve patient outcomes by enhancing clinical responses to tumor drug treatments. It also utilizes active learning asset technology for patient-centric drug discovery. On March 17, Predictive Oncology (NASDAQ:POAI) announced that it will distribute a dividend of newly designated Series F Preferred Stock, equivalent to one one-thousandth of a share, for each outstanding common share held by shareholders on record as of March 27. 

On March 17, Predictive Oncology Inc. (NASDAQ:POAI) announced that it has teamed up with Cancer Research Horizons to create cancer medications. To identify the most effective drug-tumor type combinations for clinical development, the collaboration will employ Predictive’s PEDAL technology, an artificial intelligence (AI) and machine learning platform that predicts drug responses. Cancer Research Horizons’ preclinical Glutaminase drug inhibitors will be evaluated by the partnership to determine which cancer types and patient populations are most likely to respond to treatment with these compounds.

According to Insider Monkey’s fourth quarter database, Ken Griffin’s Citadel Investment Group is the biggest stakeholder in Predictive Oncology Inc. (NASDAQ:POAI), with 87,964 shares worth nearly $27 million. 

 

1. Infobird Co., Ltd (NASDAQ:IFBD)

Average Estimated Price Target: $12.47

Number of Hedge Fund Holders: N/A

Average Upside Potential: 2,126.79%

Infobird Co., Ltd (NASDAQ:IFBD) is a Chinese company that provides artificial intelligence enabled customer engagement solutions to its clients. The company’s services include cloud-based customer relationship management (CRM) services, SaaS, and business process outsourcing. Infobird Co., Ltd (NASDAQ:IFBD) also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performances of their agents. Its corporate clients come from a range of industries, including finance, education, public services, healthcare, and consumer products. Infobird Co., Ltd (NASDAQ:IFBD) is one of the best AI stocks under $20. 

On February 24, Infobird Co., Ltd (NASDAQ:IFBD) revealed the details of its registered direct offering, which consists of roughly 3.85 million units. Each unit contains one ordinary share and 0.65 warrants to purchase one ordinary share. The units were sold at a price of $1.30 per unit. The warrants can be exercised immediately upon issuance and have an exercise price of $1.30. They will expire five years after issuance. The offering is expected to generate gross proceeds of approximately $5 million, and it concluded on February 28, 2023.

 

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily enewsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also check out 10 Best EV Battery Stocks Under $10 and 13 Best Emerging Market Stocks to Buy.